Hospitalization, major complications and mortality in acute myocardial infarction patients during the COVID-19 era: A systematic review and meta-analysis. (August 2022)

• Record Type: Journal Article
• Authors: Pourasghari, Hamid; Tavolinejad, Hamed; Soleimanpour, Samira; Abdi, Zhaleh; Arabloo, Jalal; Bragazzi, Nicola Luigi; Behzadifar, Masoud; Rashedi, Sina; Omidi, Negar; Ayoubian, Ali; Tajdini, Masih; Ghorashi, Seyyed Mojtaba; Azari, Samad
• Is Part Of: IJC heart & vasculature. Volume 41(2022)
• Publication Date: 2022-08
• Subjects: COVID-19 -- SARS-CoV2 -- Acute myocardial Infarction -- Systematic review -- Meta-analysis; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Pathophysiology -- Periodicals; 616.1005
• DOI: 10.1016/j.ijcha.2022.101058
• Languages: English
• ISSNs: 2352-9067

Abstract

Abstract: Since the SARS-CoV-2 pandemic began, numerous studies have reported a concerning drop in the number of acute myocardial infarction (AMI) admissions. In the present systematic review and meta -analysis, we aimed to compare the rate of AMI admissions and major complication during the pandemic, in comparison with pre-pandemic periods. Three major databases (PubMed, Scopus, and Web of Science Core Collection) were searched. Out of 314 articles, 41 were entered into the study. Patients hospitalized for AMI were 35% less in the COVID-19 era compared with pre-pandemic periods, which was statistically significantly (OR = 0.65; 95% CI: 0.56–0.74; I 2 = 99%; p < 0.001; 28 studies). Patients hospitalized for STEMI and NSTEMI were 29% and 34% respectively less in the COVID-19 era compared with periods before COVID-19, which was statistically significantly (OR = 0.71; 95% CI: 0.65 –0.78; I 2 = 93%; p < 0.001; 22 studies, OR = 0.66; 95% CI: 0.58–0.73; I 2 = 95%; p < 0.001; 14 studies). The overall rate of in-hospital mortality in AMI patients increased by 26% in the COVID-19 era, which was not statistically significant (OR = 1.26; 95% CI: 1.0–1.59; I 2 = 22%; p < 0.001; six studies). The rate of in-hospital mortality in STEMI and NSTEMI patients increased by 15% and 26% respectively in the COVID-19 era, which was not statistically significant (OR = 1.15; 95% CI: 0.85–1.57; I 2 = 48%; p = 0.035; 11 studies, OR = 1.35; 95% CI: 0.64–2.86; I 2 = 45%; p = 0.157; 3 articles). These observations highlight the challenges in the adaptation of health-care systems with the impact of the COVID-19 pandemic.